James Young was appointed Chief Financial Officer in January 2025. Previously he served as the Senior Vice President – Investor Relations and Treasurer of TriSalus since August 2023.
James was President of J Young Consulting LLC, where he served as an Interim CFO and also provided finance organization optimization services for small to medium sized companies, primarily in the life sciences industry. Prior to that, he held numerous progressive financial leadership roles during a 33-year career at Abbott Laboratories, including Divisional Vice President and Controller of the Diagnostics Division and Divisional Vice President and Controller of the Established Pharmaceutical Division, located in Basel, Switzerland. James also served as the Vice President and Chief Ethics and Compliance Officer for Abbott from 2015 to 2021. Prior to his time at Abbott, he was a Senior Auditor at Ernst and Whinney.
James received his BBA in Accounting from St. Norbert College and is a Certified Public Accountant, State of Wisconsin.
